Fractyl Health, Inc (GUTS): Price/Earnings to Growth Multiple

Fractyl Health, Inc. (GUTS) is deploying unique endoscopic diabetes therapy equipment into clinics, creating a steady stream of orders for consumables. The PEG ratio trend captures a peak, after which the indicator leveled off at 0.00. Fractyl Health, Inc. (GUTS) regenerates the intestinal mucosa via Revita, restoring metabolism without the use of medication. The team is expanding by recruiting leading biologists and clinical trial experts.

$GUTS fractyl.com Price/Earnings to Growth Multiple (02/21/2024 - 11/12/2026)$

Analytical breakdowns for Fractyl Health, Inc. (GUTS)

- share price and consensus valuation forecast:

Price Performance Chart Fractyl Health Inc.|GUTS - Price Target Chart

- stock exchange capitalization data:

Market Valuation Fractyl|GUTS - Enterprise Value

- book value of equity indicators:

Net Asset Value per Share Fractyl Health|GUTS - Company Net Assets|Market Cap to Book Value Multiple fractyl.com|GUTS - Company Total Assets

- debt obligations and liquidity statistics:

- earnings and multiples data:

GUTS - Company Net Income|Company Profit Forecast Fractyl Health, Inc.|GUTS - Price to Earnings Ratio|Projected Price to Earnings Fractyl Health, Inc|GUTS - PEG Multiple|Company Value to Operating Income Before Depreciation Ratio Fractyl|GUTS - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Fractyl Health|GUTS - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth fractyl.com|GUTS - Earnings growth in current year|Expected earnings per share growth for next year Fractyl Health, Inc.

Fundamental company analysis:GUTS - Fractyl Health Inc.

$Signature product of fractyl.com$

Fractyl Health, Inc. (GUTS) invests in highly skilled personnel and R&D to combat metabolic diseases. By analyzing the PEG ratio trajectory, an investor can see the relationship between market value and earnings growth rates. The current value of 0.00 reflects the efficiency of capitalizing on the company's innovative potential. A value below one signals that the asset is undervalued relative to its expansion. The market interprets such levels as a foundation for rapid price growth.

Competitors of Fractyl Health, Inc.